research grant

The platform, based on the firm's Hi-C technology, is designed to assembly viral genomes from metagenomic samples and associate them with their microbial hosts.

The grant will fund an investigation into long noncoding RNA and the role it plays in differing prognoses between Black and white breast cancer patients.

The grant, to support the work of the GenOMICC consortium, will help to identify genetic factors associated with response to the virus.

The firm has signed a three-year agreement with the University Hospital of Zurich to develop the test for use in kidney transplant recipients.

The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.

Earlier this year, Novigenix and collaborators were awarded up to €1 million to develop a blood-based multi-omics colorectal cancer assay.

The funding will help the company further develop its INSPECTR molecular diagnostic platform into a test that can be used in various settings.

The planned DNA library is expected to enable the use of environmental DNA to develop accurate species lists for a given sampled area.